Virtu Financial LLC Vallon Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

  • $1.43 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 15, 2023
SELL
$0.22 - $0.52 $5,306 - $12,541
-24,119 Reduced 18.52%
106,120 $30,000
Q3 2022

Nov 07, 2022
BUY
$0.3 - $0.68 $39,071 - $88,562
130,239 New
130,239 $37,000

About Vallon Pharmaceuticals, Inc.

VLON Quotes by TradingView
  • Ticker VLON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,512,800
  • Description
  • Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. Its lead investigational product candidate is ADAIR, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the ...
More about VLON
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email